Cited by 192Bone Metabolism and DiseasesCell death mechanisms and regulationBone health and osteoporosis research

Spatial Distribution of Bax and Bcl-2 in Osteocytes After Bone Fatigue: Complementary Roles in Bone Remodeling Regulation?

Open access
Verborgt, Olivier, Tatton, Nadine A., Majeska, Robert J., Schaffler, Mitchell B.·2002·Journal of Bone and Mineral Research

Abstract

Osteocyte apoptosis appears to play a key role in the mechanism by which osteoclastic resorption activity targets bone for removal, because osteocyte apoptosis occurs in highly specific association with microdamage and subsequent remodeling after fatigue. However, beyond terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP)-biotin nick end labeling (TUNEL) assay, little is known about the mechanisms controlling osteocyte apoptosis in vivo. In the current studies, expression of Bax, a proapoptotic gene product, and Bcl-2, an antiapoptotic gene product, was determined in osteocytes of fatigued rat bone using immunocytochemical staining and compared with TUNEL staining patterns. Bax and Bcl-2 were evident in osteocytes by 6 h after loading. Moreover, Bax and Bcl-2 in osteocytes were expressed differently as a function of distance from microdamage sites. The peak of Bax expression and TUNEL+ staining in osteocytes was observed immediately at the microcrack locus, which is where bone resorption occurs in this system; in contrast, Bcl-2 expression, the antiapoptotic signal, reached its greatest level at some distance (1-2 mm) from microcracks. These data suggest that near sites of microinjury in bone, those osteocytes that do not undergo apoptosis are prevented from doing so by active protection mechanisms. Moreover, the zone of apoptotic osteocytes around microcracks was effectively “walled in” by a surrounding halo of surviving osteocytes actively expressing Bcl-2. Thus, the expression pattern of apoptosis-inhibiting gene products by osteocytes surrounding the apoptotic osteocyte at microdamage sites also may provide important signals in the guidance of resorption processes that occur in association with osteocyte apoptosis after fatigue.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1359/jbmr.2002.17.5.907

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bystander osteocytes (in 1-2-mm proximity to the focal damage site) expressed the antiapoptotic protein BcL-2; this defense mechanism might be necessary to prevent osteoclastogenic signal damaging viable osteocytes.

    “Moreover, bystander osteocytes (in 1–2-mm proximity to the focal damage site) expressed the antiapoptotic protein BcL-2. This defense mechanism might be necessary to prevent osteoclastogenic signal damaging viable osteocytes70 (Fig. 2).”
  • A variant of RANKL with changes in the RANK binding site still activates LGR4 signaling and inhibits osteoclastogenesis; it acts as an immunogen triggering anti-RANKL antibodies and might reduce risks linked to abrupt suspension of denosumab.

    “This variant still activates LGR4 signaling and inhibits osteoclastogenesis. Moreover, it has been observed that this variant acts as an immunogen triggering the production of anti‐RANKL antibodies, and its use might reduce the risks linked to the abrupt suspension of denosumab use.173,70”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Verborgt, O., Tatton, N. A., Majeska, R. J., & Schaffler, M. B.
Affiliations
  • University of Antwerp (BE)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Schaffler, Mitchell B.
Venue
Journal of Bone and Mineral Research
Published
2002-05-01
Volume
17
Issue
5
Pages
907-914
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2029546905
Cited by
192
References
54
Citations by year
2026: 3 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 9 · 2014: 8 · 2013: 15 · 2012: 16
FWCI
1.62
Type
journal article
Language
en
Open access
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Universiteit Antwerpen
  • National Institutes of Health (AR41210)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR41210, R01AR041210)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
osteocyte apoptosis, Bax, Bcl-2, bone fatigue, microcracks, bone microdamage, bone remodeling, osteoclast resorption, apoptosis regulation, rat bone
MeSH terms
Animals, Bone and Bones, Female, Immunohistochemistry, Osteocytes, Proto-Oncogene Proteins, Stress, Mechanical, Bone Remodeling, Rats, Sprague-Dawley, Apoptosis, Proto-Oncogene Proteins c-bcl-2, bcl-2-Associated X Protein, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review